Pleiotropic effects of resveratrol

Drug News and Perspectives

Volumn 16, Issue 5, 2003, Pages 299-307

  Granados Soto, Vinicio ^a,b  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; PHYTOALEXIN; RESVERATROL;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARACHIDONIC ACID METABOLISM; CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; DRUG MECHANISM; DRUG STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE; LIPID METABOLISM; LIPID PEROXIDATION; PAIN; PHASE TRANSITION; PLEIOTROPY; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION; WINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY DISEASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GENE EXPRESSION; ISOENZYMES; NEOPLASMS; PAIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STILBENES;

EID: 0141616557     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2003.16.5.829318     Document Type: Review

References (93)

1. Nonomura, S., Kanagawa, H. and Makimoto, A. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jo-kon (Polygonum cuspidatum SIEB et ZUCC). Yakugaku Zasshi 1963, 83: 983-8.
2. Langcake, P. and Pryce, R.J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 1976, 9: 77-86.
3. Siemann, E.H. and Creasy, L.L. Concentration of phytoalexin resveratrol in wine. Am J Enol Vitic 1992, 43: 49-52.
4. Gaziano, J.M., Buring, J.E., Breslow, J.L. et al. Moderate alcohol intake, increased levels of low density lipoprotein and its subfractions and decreased risk of myocardial infarction. N Engl J Med 1993, 329: 1829-34.
5. Goldberg, D.M., Hahn, S.E. and Parkes, J.G. Beyond alcohol: Beverage consumption and cardiovascular mortality. Clin Chim Acta 1995, 237: 155-87.
6. Jang, M., Cai, L., Udeani, G.O. et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275: 218-20.
7. Uenobe, F., Nakamura, S. and Miyazawa, M. Antimutagenic effect of resveratrol against Trp-P-1. Mutat Res 1997, 373: 197-200.
8. Mgbonyebi, O.P. Russo, J. and Russo, I.H. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 1998, 12: 865-9.
9. Kimura, Y., Okuda, H. and Kubo, M. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. J Etnopharmacol 1995, 45: 131-5.
10. Pace-Asciak, C.R., Hahn, S., Diamandis, E.P., Soleas, G. and Golberg, D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary artery disease. Clin Chim Acta 1995, 235: 207-17.
11. Frémont, L. Biological effects of resveratrol. Life Sci 2000, 66: 663-73.
12. Gusman, J., Malonne, H. and Atassi, G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 2001, 22: 1111-7.
13. Kimura, Y., Okuda, H. and Arichi, S. Effects of stilbene derivatives on arachidonic metabolism in leukocytes. Biochim Biophys Acta 1985, 837: 209-12.
14. Mehta, R.G. and Moon, R.C. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol. Anticancer Res 1991, 11: 593-6.
15. Gehm, B.D., McAndrews, J.N., Chien, P.Y. and Jameson, J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogenic receptor. Proc Natl Acad Sci USA 1997, 94: 14138-43.
16. Lu, R. and Serrero, G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 1999, 179: 297-304.
17. Damianaki, A., Bakogeorgou, E., Kampa, M. et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000, 78: 429-41.
18. Dubuisson, J.G., Dyess, D.L. and Gaubatz, J.W. Resveratrol modulates human mammary epithelial cell O-acetyltransferase, sulfo-transferase, and kinase activation of the heterocyclic amine carcinogen N-hydroxy-PhIP. Cancer Lett 2002, 182: 27-32.
19. Clémen,t M.V., Hirpara, J.L., Chawdhury, S.H. and Pervaiz, S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998, 92:996-1002.
20. Ciolino, H.P., Yeh, G.C. Inhibition of arylhydrocarbon-induced cytochrome P4501A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999, 56: 760-7.
21. Ciolino, H.P., Daschner, P.J. and Yeh, G.C. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of aryl hydrocarbon receptor: Cancer Res 1998, 58: 5707-12.
22. Ratan, H.L., Steward, W.P., Gescher, A.J. and Mellon, J.K. Resveratrol-A prostate cancer chemopreventive agent? Urol Oncol 2002, 7: 223-7.
23. Ding, X.Z. and Adrian, T.E. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cells. Pancreas 2002, 25: 71-6.
24. Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B. and Ferandez-Salguero, P.M. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell specific alteration of the cell cycle. Biochem Pharmacol 2002, 64: 1375-86.
25. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C. and Guittet, O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998, 412: 277-9.
26. Sun, NJ., Woo, S.H., Cassady, J.M. and Snapka, R.M. DNA polymerase and topoisomerase II inhibitors from Psoraleas corylifolia. J Nat Prod 1998, 61: 362-6.
27. Surh, Y.J., Chun, K.S., Cha, H.H. et al. Molecular mechanisms underlying chemo-preventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NFkappaB activation. Mutat Res 2001, 480-481: 243-8.
28. Schneider, Y., Vincent, F., Duranton, B. et al. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 2000, 158: 85-91.
29. Moreno, J.J. Resveratrol modulates arachidonic acid release prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther 2000, 294: 333-8.
30. Holian, O., Wahid, S., Atten, M.J. and Attar, B.M. Inhibition of gastric cancer cell proliferation by resveratrol: Role of nitric oxide. Am J Physiol Gastrointest Liver Physiol 2002, 282: G809-16.
31. Kawada, N., Seki, S., Inoue, M. and Kuroki, T. Effect of antioxidants, resveratrol, quercetin and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatol 1998, 27: 1265-74.
32. Baht, K.P.L., Kosmeder, J.W. and Pezzuto, J.M. Biological effects of resveratrol. Anti-oxid Redox Signal 2001, 3: 1041-64.
33. Hsieh, T., Halicka, D., Lu, X. et al. Effects of resveratrol on the Go-Gi transition and cell cycle progression of mitogenically stimulated human lymphocytes. Biochem Byophys Res Commun 2002, 297: 1311-7.
34. Howe, L.R., Subbaramaiah, K., Brown, A.M.C. and Dannenberg, A.J. Cyclooxygenase-2: A target for the prevention and treatment of breast cancer. Endocr Relat Cancer 2001, 8: 97-114.
35. Holmes-McNary, M. and Baldwin, A.S. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 2000, 60: 3477-83.
36. Ferry-Dumazet, H., Gamier, O., Mamani-Matsuda, M. et al. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 2002, 23: 1327-33.
37. Huang, C., Ma, W.Y., Goranson, A., Dong, Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999, 20: 237-42.
38. Lin, H.Y., Shih, A., Davis, F.B. et al. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 2002, 168: 748-55.
39. Banerjee, S., Bueso-Ramos, C. and Aggarwal, B.B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002, 62: 4945-54.
40. MacCarrone, M., Lorenzon, T., Guerrieri, P. and Agro, A.F. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 1999, 265: 27-34.
41. Klatsky, A.L., Friedman, G.D. and Siegelaub, A.B. Alcohol consumption before myocardial infarction. Results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intem Med 1974, 81: 294-301.
42. Rimm, E.B., Givannucci, E.L., Willett, W.C. et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991, 339: 464-8.
43. Klurfeld, D.M. and Kritchevsky, D. Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits. Exp Mol Pathol 1981, 34: 62-71.
44. Seigneur, M., Bonnet, J., Dorian, B. et al. Effect of the consumption of alcohol, white wine and red wine on platelet function and serum lipids. J Appl Cardiol 1990, 5: 215-22.
45. Arichi, H., Kimura, Y., Okuda, H., Baba, K., Kozawa, M. and Arichi, M. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb et Zucc. on lipid metabolism. Chem Pharm Bull 1982, 30: 1766-79.
46. 2 production in vitro. Acta Pharmacol Sin 1990, 11: 527-30.
47. Ragazzi, E., Froldi, G. and Fassina, G. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals. Pharmacol Res Commun 1988, 20(Suppl 5): 79-82.
48. Elwood, P.C., Renaud, S., Sharp, D.S., Beswick, A.D., O'Brian, J.R. and Yarnell, J.W. Ischemic heart disease and platelet aggregation. Circulation 1991, 83: 38-44.
49. Bertelli, A.A., Giovannini, L., Giannessi, D. et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995, 17: 1-3.
50. Olas, B., Wachowicz, B., Saluk-Juszczak, J. and Zielinski, T. Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Throm Res 2002, 107: 141-5.
51. Wang, Z., Huang, Y., Zou, J., Cao, K., Xu, Y. and Wu, J.M. Effects of red wine polyphenol resveratol on platelet aggregation in vivo and in vitro. Int J Mol Med 2002, 9: 77-9.
52. Subbramaiah, K., Chung, W.J., Michaluart, P. et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998, 273: 21875-82.
53. Frankel, E.N., Waterhouse, A.L. and Kinsella, J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993, 341: 1103-4.
54. Martinez, J. and Moreno, J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000, 59: 865-70.
55. Bastianetto, S., Zheng, W.H. and Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 2000, 131: 711-20.
56. Sinha, K., Chaudhary, G. and Gupta, Y.K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002, 71: 655-65.
57. Ray, P.S., Maulik, G., Gordis, G.A., Bertelli, A.A.E., Bertelli, A. and Das, D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 1999, 27: 160-9.
58. Wu, J.M., Wang, Z.R., Hsieh, T.C., Bruder, J.L., Zou, J.G. and Huang, Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present red wine. Int J Mol Med 2001, 8: 3-17.
59. Hung, L.M., Su, M.J., Chu, W.K., Chiao, Ch. W., Fan, W.F. and Chen, J.K. The protective effect of resveratrol on ischemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 2002, 135: 1627-33.
60. Imamura, G., Bertelli, A.A., Bertelli, A., Otani, H., Maulik, N. and Das, D.K. Pharmacological preconditioning with resveratrol: An insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 2002, 282: H1996-H2003.
61. Hattori, R., Otani, H., Maulik, N. and Das, D.K. Pharmacological preconditioning with resveratrol: a tole of nitric oxide. Am J Physiol Heart Circ Physiol 2002, 282: H1988-H1995.
62. Chen, C.K. and Pace-Asciak, C.R. Vaso-relaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 1996, 27: 363-6.
63. Orallo, F., Alvarez, E., Camina, M. et al. The possible implication of Trans-resveratrol in the cardioprotective effect of long-term moderate wine consumption. Mol Pharmacol 2002, 61: 294-302.
64. Wallerath, T., Deckert, G., Temes, T. et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002, 106: 1652-8.
65. El-Mowafy, A.M. Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection. Biochem Biophys Res Commun 2002, 291: 1218-24.
66. Soderling, S.H. and Beavo, J.A. Regulation of cAMP and cGMP signaling, new phosphodiesterases and new functions. Curr Opin Cell Biol 2000, 12: 174-9.
67. Schwartz, Z., Sylvia, V.L., Del Toro, F., Hardin, R.R., Dean, D.D. and Boyan, B.D. 24R,25-(OH)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in grow plate chondrocytes. J Cell Physiol 2000, 182: 390-401.
68. Brzozowski, T., Konturek, P.C., Konturek, S.J. et al. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gut lesions. Eur J Pharmacol 2000, 385: 47-61.
69. Torres-López, J.E., Alonso-López, R., Asomoza-Espinosa, R. and Granados-Soto, V. Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test. Life Sci 2002, 70: 1669-76.
70. Gentilli, M., Mazoit, J.X., Bouaziz, H. et al. Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci 2001, 68: 1317-21.
71. Granados-Soto, V., Torres-López, J.E., Argüelles, C.F. and Ortiz, M.I. The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels. Neuropharmacol 2002, 43: 917-23
72. + current in vascular endothelial cells. Cardiovasc Res 2000, 45: 1035-945.
73. + channel blocker antagonises morphine analgesia. Eur J Pharmacol 1990, 186: 377-8.
74. + channels. Br J Pharmacol 2000, 129: 110-4.
75. + channels by diclofenac. Eur J Pharmacol 2002, 438: 85-91.
76. + channels. Pharmacol Biochem Beh 2003, 74: 465-70.
77. Basly, J.P., Marre-Foumier, F., Le Bail, J.C., Habrioux, G. and Chulia, A.J. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci 2000, 66: 769-77.
78. Bertelli, A.A., Bertelli, A., Gozzini, A. and Giovannini, L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drug Exp Clin Res 1998, 24: 133-8.
79. Bertelli, A.A., Giovannini, L., Stradi, R., Urien, S., Tillement, J.P. and Bertelli, A. Kinetics of trans- and cis-resveratrol (3,4,5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res 1996, 16: 77-81.
80. Bertelli, A.A., Giovannini, L., Stradi, R., Tillement, J.P. and Bertelli, A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drug Exp Clin Res 1998, 24: 51-5.
81. Kuhnle, G., Spencer, J.P., Chowrimootoo, G. et al. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 2000, 272: 212-7.
82. Andlauer, W., Kolb, J., Siebert, K. and Furst, P. Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Exp Clin Res 2000, 26: 47-55.
83. Marier, J.F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J.P. and Ducharme Duchanne, M.P. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002, 302: 369-73.
84. Pace-Asciak, C.R., Rounova, O., Hahn, S. et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996, 246: 163-82.
85. Goldberg, D.M., Garovic-Kocic, V., Diamandis, E.P. and Pace-Asciak, C.R. Wine: Does the colour count? Clin Chim Acta 1996, 246: 183-93.
86. Creasy, L.L. and Coffee, M. Phytoalexin production potential of grape berries. J Am Soc Hort Sci 1988, 113: 230-4.
87. Chanvitayapongs, S., Draczynska-Lusiak, B., Sun, A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 1997, 8: 1499-502.
88. +-ATPase. Biochem Pharmacol 1992, 44: 1947-51.
89. Jayatilake, G.S., Jayasuriya, H., Lee, E.S. et al. Kinase inhibitors from Polygonum cuspidatum. J Nat Prod 1993, 56: 1805-10.
90. Belguendouz, L., Fremont, L. and Linard, A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 1997, 53: 1347-55.
91. Belguendouz, L., Fremont, L. and Gozzelino, M.T. Interaction of trans-resveratrol with plasma lipoproteins. Biochem Pharmacol 1998, 55: 811-6.
92. Rotondo, S., Ratjtar, G., Manarini, S. et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998, 123: 1691-9.
93. Yoon, S.H., Kim, Y.S., Ghim, S.Y., Song, B.H. and Bae, Y.S. Inhibition of protein kinase CKII activity by resveratrol, a natural compound in red wine and grapes. Life Sci 2002, 71: 2145-52.